BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  San Diego’s Pfenex Regains Full Rights to PF582 and Announces Phase I/II Results

  August 8, 2016

   · 

  6 min read
• Deals

  Sorrento Subsidiary Pays $70 Million in Stock for Scilex

  August 8, 2016

   · 

  5 min read
• Policy

  Wockhardt Plunges On U.S. Ban On Third Drug-Making Factory

  August 8, 2016

   · 

  1 min read
• Business

  Ritter Pharmaceuticals, Inc. Reports Second Quarter 2016 Financial Results And Provides Business Update

  August 8, 2016

   · 

  10 min read
• Deals

  Celgene Passes on Option-to-Buy $600 Million Deal for Boston’s Acetylon

  August 8, 2016

   · 

  1 min read
• Pharm Country

  Deficiencies Force Pfizer to Shut Down Indian Facility Temporarily

  August 8, 2016

   · 

  1 min read
• Drug Development

  Novartis AG’s New Asthma Drug Hailed a Game-Changer After Success in Small Trial

  August 8, 2016

   · 

  1 min read
• Deals

  Zoetis Makes $80 Million Buy to Extend Its Pipeline in Diagnostics

  August 8, 2016

   · 

  7 min read
• Business

  Cellectar Biosciences To Host Conference Call On August 15 To Report Second Quarter 2016 Financial Results And Corporate Performance

  August 8, 2016

   · 

  3 min read
• Business

  Embattled Valeant Shakes Up Executive Team in Strategic Plan to Create a Whole New Company

  August 8, 2016

   · 

  6 min read